Aayush Wellness Expands Horizons with Strategic Entry into $25 Billion Diagnostic Segment
Apr 15, 2025
New Delhi [India], April 15: One of the biggest BSE-listed (539528) Aayush Wellness Limited, a trusted name in the nutraceutical industry, has announced its strategic foray into the diagnostics space as part of its next growth phase, driven by the innovative Genome Testing technology. India's diagnostics industry is projected to reach $25 billion by 2028, with the potential to grow up to $40 billion, while the global diagnostics market is expected to grow to $272.98 billion by 2032.
Read More ..
